Early Treatment Withdrawal from Evidence-Based Psychotherapy for PTSD: Telemedicine and in-Person Parameters

• DOI: 10.2190/pm.48.1.d
• Publication Date: 2014-10-30T01:23:26Z
• Authors: Melba A. Hernande...; James S. Zoller; Kenneth J. Ruggiero; Abby Swanson Kazley; Ron Acierno
• Keywords: Adult; Male; Patient Dropouts; 05 social sciences; Implosive Therapy; Middle Aged; 16. Peace & justice; Telemedicine; United States; 3. Good health; Psychotherapy; Stress Disorders, Post-Traumatic; Young Adult; Evidence-Based Practice; Humans; Patient Compliance; 0501 psychology and cognitive sciences; Aged; Randomized Controlled Trials as Topic; Veterans

Objective: To determine differences in reported barriers to treatment completion associated with telemedicine vs. in-person delivery of evidence-based treatment for PTSD in combat veterans. Method: The present study was derived from two ongoing randomized controlled trials (RCTs) comparing in-person vs. telemedicine delivery of exposure therapy for PTSD. A onetime telephone assessment of participants who dropped out from the treatment phase of these two studies was conducted, with measures focusing on reported reasons for dropout, and perceived comfort and efficacy of the treatment modality. Dichotomous data were analyzed via chi-square and logistic regression; continuous data via ANOVA. Results: Forty-seven of 69 total dropouts participated. There was no difference in rate of dropout between modalities. A greater proportion of participants receiving in-person exposure therapy reported difficulties with logistical aspects of care (e.g., parking), whereas a greater proportion of participants receiving telemedicine therapy reported difficulty tolerating certain stressful aspects of treatment; however, those receiving telemedicine delivered treatment completed more sessions before dropping out. Participants in both conditions reported that they liked and were confident in their therapist Conclusions: Dropout reasons varied according to type of treatment delivery. Recommendations for future research are given in terms of modification of treatment protocol according to delivery modality.